Y M Kirova

Summary

Affiliation: Institut Curie
Country: France

Publications

  1. ncbi request reprint Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation
    Fatima Laki
    Department of Surgery, Institut Curie, Paris, France
    Cancer 109:1784-90. 2007
  2. ncbi request reprint Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 68:359-63. 2007
  3. doi request reprint [Monocentric evaluation of the skin and cardiac toxicities of the concomitant administration of trastuzumab and radiotherapy]
    Y M Kirova
    Département d Oncologie Radiothérapie, Institut Curie, 26 Rue d Ulm, Paris Cedex 05, France
    Cancer Radiother 13:276-80. 2009
  4. doi request reprint Case study thoracic radiotherapy in an elderly patient with pacemaker: the issue of pacing leads
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Med Dosim 37:192-4. 2012
  5. doi request reprint Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapy
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, 26, rue d Ulm, 75248, Paris Cedex 05, France
    Invest New Drugs 30:1241-3. 2012
  6. pmc Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death
    Romuald Le Scodan
    Department of Radiation Oncology, centre hospitalier privé Saint Grégoire, Saint Grégoire, France
    BMC Cancer 11:395. 2011
  7. doi request reprint Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patients
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 78:1352-5. 2010
  8. doi request reprint Can we consider always an esophageal carcinoma as radiation associated cancer after irradiation for breast cancer?
    Youlia M Kirova
    Departments of Radiation, Oncology Institute Curie, Paris, France
    Am J Clin Oncol 32:197-9. 2009
  9. doi request reprint [Multiple brain metastases after breast cancer and their radiotherapy management: what is the optimal treatment?]
    Youlia M Kirova
    Institut Curie, Département d Oncologie Radiothérapie, 26, rue d Ulm, 75005 Paris, France
    Bull Cancer 98:409-15. 2011
  10. pmc Second malignancies after breast cancer: the impact of different treatment modalities
    Y M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Br J Cancer 98:870-4. 2008

Collaborators

Detail Information

Publications58

  1. ncbi request reprint Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation
    Fatima Laki
    Department of Surgery, Institut Curie, Paris, France
    Cancer 109:1784-90. 2007
    ..Prophylactic salpingo-oophorectomy (SO), which is recommended in BRCA1/2 mutation carriers, still needs to be reappraised...
  2. ncbi request reprint Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 68:359-63. 2007
    ..The aim of this study was to estimate the risk of second malignancies (SM) after radiation therapy (RT) for breast cancer (BC) in a large, institutional, homogeneous cohort of patients...
  3. doi request reprint [Monocentric evaluation of the skin and cardiac toxicities of the concomitant administration of trastuzumab and radiotherapy]
    Y M Kirova
    Département d Oncologie Radiothérapie, Institut Curie, 26 Rue d Ulm, Paris Cedex 05, France
    Cancer Radiother 13:276-80. 2009
    ..Prospective monocentric study of the skin and heart tolerance of a concurrent administration of trastuzumab (T) and radiotherapy (RT) for breast cancer (BC)...
  4. doi request reprint Case study thoracic radiotherapy in an elderly patient with pacemaker: the issue of pacing leads
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Med Dosim 37:192-4. 2012
    ..This case report shows we were able to safely treat our patient through a multidisciplinary approach, monitoring the patient during each step of the treatment...
  5. doi request reprint Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapy
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, 26, rue d Ulm, 75248, Paris Cedex 05, France
    Invest New Drugs 30:1241-3. 2012
    ..However, recent data have shown that the m-TOR inhibitors could decrease the tumor resistance to ionizing radiation. At the same time, new highly conformal irradiation modalities may significantly improve the tolerance to radiation...
  6. pmc Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death
    Romuald Le Scodan
    Department of Radiation Oncology, centre hospitalier privé Saint Grégoire, Saint Grégoire, France
    BMC Cancer 11:395. 2011
    ..To access the prognostic significance of HER-2 overexpression, the effect of trastuzumab and the cause of death in patients with brain metastases (BM) from breast cancer (BC)...
  7. doi request reprint Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patients
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 78:1352-5. 2010
    ..To evaluate the accuracy of a boost technique...
  8. doi request reprint Can we consider always an esophageal carcinoma as radiation associated cancer after irradiation for breast cancer?
    Youlia M Kirova
    Departments of Radiation, Oncology Institute Curie, Paris, France
    Am J Clin Oncol 32:197-9. 2009
    ....
  9. doi request reprint [Multiple brain metastases after breast cancer and their radiotherapy management: what is the optimal treatment?]
    Youlia M Kirova
    Institut Curie, Département d Oncologie Radiothérapie, 26, rue d Ulm, 75005 Paris, France
    Bull Cancer 98:409-15. 2011
    ..Further assessment is required and recruitment of breast cancer patients into clinical trials is encouraged...
  10. pmc Second malignancies after breast cancer: the impact of different treatment modalities
    Y M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Br J Cancer 98:870-4. 2008
    ..This increase may be related to adjuvant treatment in some cases. However, the absolute risk is small...
  11. doi request reprint How to boost the breast tumor bed? A multidisciplinary approach in eight steps
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 72:494-500. 2008
    ..To describe a new procedure for breast radiotherapy that will improve tumor bed localization and radiotherapy treatment using a multidisciplinary approach...
  12. doi request reprint Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Radiother Oncol 100:205-9. 2011
    ..Preliminary results with Hyaluronic acid, one of the most recent topical products used in this indication are proving interesting. To evaluate the efficacy of Hyaluronic acid compared to placebo...
  13. pmc Simplified rules for everyday delineation of lymph node areas for breast cancer radiotherapy
    Y M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Br J Radiol 83:683-6. 2010
    ..In conclusion, this small guide is useful for improving everyday practice and decreasing the differences in target delineation for breast irradiation between institutions and observers...
  14. ncbi request reprint Postmastectomy electron beam chest wall irradiation in women with breast cancer: a clinical step toward conformal electron therapy
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 69:1139-44. 2007
    ..The purpose of this report was to show the latest improvements of our technique developed to avoid hot spots and improve the homogeneity...
  15. doi request reprint Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, 26 Rue d Ulm, 75248, Paris Cedex 05, France
    Breast Cancer Res Treat 120:119-26. 2010
    ..4 years of follow-up, the rate of ipsilateral tumours was no higher in mutation carriers than in non-carriers or controls. As tumours in BRCA1/2 mutation carriers might be more sensitive to radiation, BCT is a possible treatment option...
  16. ncbi request reprint Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Cancer 104:856-63. 2005
    ..Sarcomas are a rare complication of radiotherapy for breast carcinoma and patients have a poor prognosis. The incidence, histology, and management of patients with sarcomas were reviewed in the current study...
  17. ncbi request reprint Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, 26 Rue d Ulm, 75248 Paris, Cedex 05, France
    Eur J Cancer 41:2304-11. 2005
    ..Therefore, breast-conserving treatment can be offered to these patients. However, longer follow-up is needed to ensure that the rate of new primary cancer in the treated breast does not increase in the long-term...
  18. ncbi request reprint [Radiation-induced sarcomas after breast cancer: experience of Institute Curie and review of literature]
    Y Kirova
    Departement de Radiotherapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 10:83-90. 2006
    ..The incidence, histology, latency of appearance, genesis, their treatment and the prognostic factors of these rare tumors are discussed and the literature is reviewed...
  19. ncbi request reprint CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Radiother Oncol 79:310-5. 2006
    ....
  20. ncbi request reprint [Definition of nodal volumes in breast cancer treatment and segmentation guidelines]
    Y M Kirova
    Département d Oncologie Radiothérapie, Institut Curie, 26, rue d Ulm, 75005 Paris
    J Radiol 90:747-51. 2009
    ..The following critical organs were also segmented: heart, lungs, contralateral breast, thyroid, esophagus and humeral head...
  21. doi request reprint Use of deformable image fusion to allow better definition of tumor bed boost volume after oncoplastic breast surgery
    Youlia M Kirova
    Radiation Oncology, Institut Curie, 26, rue d Ulm, 75005, Paris, France
    Surg Oncol 20:e123-5. 2011
    ..This multidisciplinary study based on image registration was designed to propose practical solutions for the definition of tumor bed boost in this setting...
  22. doi request reprint Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy
    Youlia M Kirova
    Department of Radiation Oncology, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 75:76-81. 2009
    ....
  23. doi request reprint [Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy]
    J Jacob
    Departement de Radiotherapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 17:183-90. 2013
    ..Prospective monocentric study of the toxicities related to concurrent administration of trastuzumab to breast radiotherapy...
  24. doi request reprint [Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?]
    C Daveau
    Departement de Radiotherapie, Institut Curie, 26 Rue d Ulm, 75005 Paris, France
    Cancer Radiother 15:106-14. 2011
    ..To determine whether exclusive radiotherapy could be a therapeutic option after complete clinical response (cCR) to neoadjuvant chemotherapy (NCT) for early breast cancers (EBC)...
  25. doi request reprint Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers
    P Castro Pena
    Department of Radiation Oncology, Institut Curie, Paris, France
    Br J Radiol 82:595-9. 2009
    ..This study led to the development of written delineation protocols. The study is ongoing with evaluation of the dosimetric impact and definition of different target volumes...
  26. doi request reprint Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer
    F C Bidard
    Department of Medical Oncology, Institut Curie, Paris, France
    Ann Oncol 20:1836-41. 2009
    ..Our aim was to determine whether BM DTC detection could be related to specific locoregional dissemination of cancer cells, according to radiotherapy volumes...
  27. doi request reprint [Supra- and infraclavicular lymph node irradiation in breast cancer patients: state of the art]
    P Auberdiac
    Departement de Radiotherapie, Institut de Cancérologie de la Loire, Saint Priest en Jarez, France
    Cancer Radiother 16:237-42; quiz 243. 2012
    ..This article reviews the literature on radiation of supra- and infraclavicular lymph nodes, with a special focus on technical aspects in delineation and its potential toxicity...
  28. doi request reprint [Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie]
    S Haberer
    Département de Radiothérapie Oncologique, Institut Curie, 26 Rue d Ulm, Paris Cedex 05, France
    Cancer Radiother 13:305-12. 2009
    ..Given the scarcity of malignant phyllode tumours of the breast and the absence of consensus regarding their management justify the need for institutional retrospective evaluations of clinical practices...
  29. pmc High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies
    M A Bollet
    Department of Radiation Oncology, Institut Curie, Paris Cedex 05, Paris 75248, France
    Br J Cancer 98:734-41. 2008
    ..The lobular type had no adverse effect, neither on locoregional control nor on overall survival, even in the group of patients treated with breast conservation...
  30. doi request reprint [Radiotherapy for breast cancer and pacemaker]
    J Menard
    Oncologie radiothérapie, Institut Curie, Paris, France
    Cancer Radiother 15:197-201. 2011
    ..We studied the breast cancer patients who needed breast and/or chest wall and lymph node irradiation to assess the feasibility and tolerance in this population of patients...
  31. doi request reprint Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes
    C E de Almeida
    Department of Radiation Oncology, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 16:44-51. 2012
    ..To assess the benefits of using cardiac gated images for treatment planning of breast and internal mammary nodes...
  32. pmc Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning
    S Vennarini
    Department of Radiation Oncology, Institut Curie, Paris, France
    Br J Radiol 86:20120643. 2013
    ..To assess the visualisation of the left anterior descending (LAD) coronary artery on CT images used for breast radiation treatment planning...
  33. doi request reprint [Hypofractionated breast radiotherapy in 13 fractions, perfect tolerance or delayed early reaction? Prospective study of Curie Institute]
    M Botti
    Radiation Oncology, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 13:92-6. 2009
    ..To assess the skin toxicity of this scheme and the time to its appearance...
  34. doi request reprint [Adjuvant irradiation in breast cancer patients with ATM gene heterozygous mutations: special focus on clinical efficacy/toxicity]
    C Chargari
    Departement de Radiotherapie, Institut Curie, 75005 Paris, France
    Cancer Radiother 13:164-72. 2009
    ..Considering the lack of prospective data, patients with ATM mutation should be considered as candidates for both dose volume and dose reduction clinical trials...
  35. doi request reprint [A case of cutaneous mammary re-irradiation]
    J Jacob
    Departement de Radiotherapie, Institut Curie, Paris, France
    Cancer Radiother 16:638-40. 2012
    ..The patient was treated by re-irradiation performed concomitantly to oral chemotherapy by capecitabine...
  36. ncbi request reprint The use of computed tomography in radiotherapy treatment planning for breast cancer. How does conventional radiotherapy planning compare with virtual?
    O Bauduceau
    Department of Radiation Oncology, du Val de Grace hospital, Paris, France
    J BUON 13:245-51. 2008
    ..To compare, in terms of ballistics and dosimetry, a conventional and a virtual simulation in 14 patients without changing the set-up...
  37. doi request reprint [Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma]
    S Haberer
    Departement de Radiotherapie, Institut Curie, Paris, France
    Cancer Radiother 16:128-35. 2012
    ..To report characteristics and outcome of breast cancer after irradiation for Hodgkin lymphoma with special focus on breast conservation surgery...
  38. doi request reprint [Locally advanced (neglected) breast cancer: the reality? Relevance of two cases and reflection how to optimise the multidisciplinary approach]
    L Monnier
    Département d Oncologie Radiothérapie, Institut Curie, 26 Rue d Ulm, Paris, France
    Cancer Radiother 13:333-6. 2009
    ..Two cases of extremely advanced non operable T4 stage breast cancer are reported and the importance of multidisciplinary approach is discussed. The place and the right time of radiotherapy in this multidisciplinary strategy is reported...
  39. ncbi request reprint Breast radiotherapy in women with pectus excavatum (funnel chest): is the lateral decubitus technique an answer? A dosimetric study
    M A Bollet
    Department of Radiation Oncology, Institut Curie, Paris, France
    Br J Radiol 79:785-90. 2006
    ..ILD is an effective breast radiotherapy technique for patients with pectus excavatum that preserves the underlying heart and lung from unnecessary toxicity...
  40. doi request reprint Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage
    Amélie Monteau
    Department of Radiation Oncology, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 75:1021-8. 2009
    ..Following breast-conserving surgery for DCIS, reexcision before radiotherapy is recommended when margins are close or involved. We investigated whether an additional radiation dose could replace reexcision...
  41. doi request reprint [Internal mammary chain irradiation in breast cancer: state of the art]
    P Auberdiac
    Unité de Curiethérapie, Departement de Radiotherapie, Institut de Cancérologie de la Loire, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint Priest en Jarez Cedex, France
    Cancer Radiother 15:148-53. 2011
    ..This review of literature presents the state of art on the radiotherapy of internal mammary chain, with special focus on the indications, techniques, and potential toxicity...
  42. doi request reprint [Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience]
    Y M Kirova
    Groupe de gynécologie, service d oncologie et de radiothérapie, Institut Curie, 26 Rue d Ulm, Paris Cedex 05, France
    Cancer Radiother 13:291-7. 2009
    ..To evaluate the treatment results of patients (pts) with Figo stage IB2, IIA, IIB cervical carcinoma (CC) treated with preoperative radiochemotherapy, followed by extended radical hysterectomy...
  43. doi request reprint Management of operable invasive breast cancer in women over the age of 70: long-term results of a large-scale single-institution experience
    Fatima Laki
    Department of Surgery, Institut Curie, Paris, France
    Ann Surg Oncol 17:1530-8. 2010
    ..This retrospective analysis of a cohort from a single institution was designed to evaluate whether such patients are really undertreated because of their age and to reappraise their usual management...
  44. doi request reprint Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations status
    Alain Fourquet
    Departments of Radiation Oncology, Institut Curie, Paris, France
    Am J Clin Oncol 32:127-31. 2009
    ..BRCA1/2 germline mutations are associated with impaired DNA double-strand break repair. We tested whether breast cancers in BRCA1/2 mutation carriers were more responsive to induction treatments than in noncarriers...
  45. ncbi request reprint Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first
    Marc A Bollet
    Department of Radiation Oncology, Institut Curie, Paris, France
    Radiother Oncol 82:272-80. 2007
    ....
  46. ncbi request reprint Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation
    Francois Campana
    Department of Radiation Oncology, Institute Curie, Paris, France
    Int J Radiat Oncol Biol Phys 61:1348-54. 2005
    ..To present an original technique for breast radiotherapy, with the aim of limiting lung and heart irradiation, satisfying quality assurance criteria...
  47. doi request reprint Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients
    Cyrus Chargari
    Department of Radiation Oncology, Institut Curie, Paris, France
    J Neurooncol 93:379-84. 2009
    ..Although promising, these preliminary data warrant further assessment of capecitabine-based chemoradiation in brain metastases from breast cancer and need to be further validated in the setting of a clinical trial...
  48. ncbi request reprint Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study
    Marc A Bollet
    Department of Radiotherapy, Institut Curie, 26 Rue d Ulm, 75005 Paris, France
    Eur J Cancer 42:2286-95. 2006
    ..Grade 4 haematological toxicity occurred in 22% of patients. In conclusion, chemoradiotherapy demonstrated good efficacy, both in terms of pCR and in allowing breast conservation with acceptable tolerance...
  49. doi request reprint Prognostic factors for local recurrence following breast-conserving treatment in young women
    Marc A Bollet
    Department of Radiation Oncology, Institut Curie, Paris Cedex 05, Paris 75248, France
    Expert Rev Anticancer Ther 10:1215-27. 2010
    ..Finally, we will present a perspective of what the future could hold, both in terms of the selection of the patients and of a more customized therapeutic approach...
  50. ncbi request reprint Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women
    Marc A Bollet
    Department of Radiation Oncology, Institut Curie, 26 Rue d Ulm, Paris Cedex 05, France
    Radiother Oncol 85:336-45. 2007
    ..This study aimed to evaluate responses and outcome of hormone-therapy (HT) and radiotherapy (RT) given concurrently for large breast cancers in post-menopausal women...
  51. doi request reprint [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer]
    X Liem
    Département d Oncologie Radiothérapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France Département universitaire de radiothérapie curiethérapie, Centre Oscar Lambret, Université Nord de France, 59800 Lille, France
    Cancer Radiother 18:15-22. 2014
    ..To evaluate the dosimetry and acute toxicity of helical tomotherapy for locoregional irradiation of patients after breast-conserving surgery...
  52. doi request reprint [Importance of local skin treatments during radiotherapy for prevention and treatment of radio-induced epithelitis]
    C Chargari
    Département de Radiothérapie Oncologique, Institut Curie, 26 Rue d Ulm, Paris, France
    Cancer Radiother 13:259-66. 2009
    ..New topics are under investigation. Present data from the literature highlight the need for further trials, in order to propose evidence-based treatments and to harmonize clinical practice...
  53. doi request reprint Simultaneous integrated boost in breast conserving treatment of breast cancer: a dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapy
    Tarek Hijal
    Department of Radiation Oncology, Institut Curie, Paris, France
    Radiother Oncol 94:300-6. 2010
    ..To evaluate the dosimetry of helical tomotherapy (HT) and three-dimensional conformal radiotherapy (3D-CRT) in breast cancer patients undergoing whole breast radiation with simultaneous integrated boost (SIB) of the tumor bed...
  54. doi request reprint Solitary plasmocytoma: improvement in critical organs sparing by means of helical tomotherapy
    Cyrus Chargari
    Department of Radiation Oncology, Institut Curie, Paris, France
    Eur J Haematol 83:66-71. 2009
    ..Helical tomotherapy (HT) was assessed in two patients with paramedullar solitary bone plasmocytoma. We compared doses delivered to critical organs, according HT plan or tridimensional conformal plan...
  55. pmc Preliminary experience of helical tomotherapy for locally advanced pancreatic cancer
    Cyrus Chargari
    Department of Radiotherapy, Institut Curie, 75248 Paris, France
    World J Gastroenterol 15:4444-5. 2009
    ..Doses to the bowel, kidneys and liver were reduced significantly, which allowed for excellent treatment tolerance without any high-grade adverse effects in either patient...
  56. doi request reprint Concurrent radiation therapy and bortezomib in myeloma patient
    Oscar Berges
    Radiother Oncol 86:290-2. 2008
  57. ncbi request reprint Concurrent radiation therapy and lenalidomide in myeloma patient
    Virginie Marchand
    Radiother Oncol 87:152-3. 2008
  58. ncbi request reprint Breast lipoma
    Youlia M Kirova
    Department of Cancerology, Henri Mondor University Hospital, 51 Av du Marechal de Lattre de Tassigny, 94010 Creteil, France
    Breast J 8:117-8. 2002